226. Interstitial cystitis with Hunners ulcer Clinical trials / Disease details

Clinical trials : 145 / Drugs : 156 - (DrugBank : 51) / Drug target genes : 64 - Drug target pathways : 146

2 trials found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04401176 (ClinicalTrials.gov)	September 15, 2020	19/5/2020	Bladder Instillations Versus Onabotulinumtoxin A for Treatment of Interstitial Cystitis/Bladder Pain Syndrome	A Randomized Trial of Bladder Instillations Versus Onabotulinumtoxin A for Treatment of Interstitial Cystitis/Bladder Pain Syndrome	Interstitial Cystitis;Bladder Pain Syndrome	Drug: Heparin & Alkalinized Lidocaine Bladder Instillation;Drug: Onabotulinum Toxin A	Walter Reed National Military Medical Center	NULL	Active, not recruiting	18 Years	N/A	Female	58	Phase 2	United States
2	NCT02297100 (ClinicalTrials.gov)	December 2014	30/9/2014	Intravesicular Onabotulinumtoxin A in Interstitial Cystitis	The Impact of Injection Location on the Efficacy of Intravesicular Onabotulinumtoxin A in Interstitial Cystitis--Phase 4	Interstitial Cystitis	Drug: Onabotulinumtoxin A;Procedure: injections upper aspect of trigone of urinary bladder;Procedure: injections on posterior bladder wall excluding the trigone	Wake Forest University Health Sciences	Allergan	Completed	18 Years	80 Years	Female	27	Phase 4	United States